MORRIS PLAINS, N.J., June 16, 2011 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that Gerard G. Gorman, Senior Vice President of Finance and Business Development, and Chief Financial Officer, will present at the 2011 Wells Fargo Securities Healthcare Conference on Thursday, June 23th at 1:30 pm at The InterContinental Boston. The presentation, which will provide a corporate overview, can be downloaded simultaneously at www.immunomedics.com/1aboutus/present.pdf.
